Automated deep learning system that identifies various retinal diseases from fundus photographs. Provides comprehensive retinal disease screening capability integrated into routine eye examination workflows.
Manufactured by
Mediwhale Inc.
Seoul, South Korea
The first comprehensive AI diagnostic solution Dr. Noon is the first comprehensive AI diagnostic solution to predict cardiovascular, kidney, eye diseases, and biological age through retinal images as a biomarker. Mediwhale is turning simple and effective AI diagnostic solutions into reality, empowering everyone to benefit from preventive healthcare.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
CHECK-EYE
Germany · 1 relevant product
APOLO AI SYSTEMS AND DEVELOPMENT S.L.
Spain · 1 relevant product
Optain Health
Australia · 1 relevant product
1 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 4 closest product alternatives
CHECK-EYE · Germany
Specialized diagnostic tool designed to screen for diabetic retinopathy in patients with diabetes mellitus. Utilizes artificial intelligence to detect retinal alterations indicative of disease progression. Provides rapid assessment without the need for dilating drops or specialized ophthalmologic equipment.
APOLO AI SYSTEMS AND DEVELOPMENT S.L. · Spain
Artificial intelligence system designed to identify subtle disease indicators through analysis of medical data. The technology enables early detection and timely clinical intervention for more effective patient treatment outcomes.
Optain Health · Australia
Non-invasive screening system utilizing AI algorithms to detect referable retinal diseases and chronic conditions from fundus images. The system generates comprehensive health risk reports for population screening and disease risk stratification.
1 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products